AARTIPHARM / Q1-FY26 / claim-ledger

Audit the questions that mattered.

Aarti Pharmalabs · Analyst questions, management answers, and the quality of the response where the ledger is available.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

WatchQ1-FY26 · 2025-08-14Back to quarter ↗

Questions audited

Answered directly

42%

Numeric claims

Consistency

contradicted

Question ledger

What was answered, and how?

Rahul Jan · Gradians Wealth

direct

What was the sales impact of the plant shutdown?

The plan shutdown sales impact would be around 15 to 20 cr rupes.

Rahul Jan · Gradians Wealth

partial

Why did intermediate sales decline from 170 to 150 cr?

No. If you see uh in this quarter we have had uh higher inventory because you know the shipments uh were little impacted towards the end of the quarter due to unavailability of uh shipping space...

Rahul Jan · Gradians Wealth

evasive

How will gross margins trend going forward?

I think in terms of margin of course you know this year was a higher margin uh because you know this inventory had an impact... product mix that we have played and which has yielded in better margins.

Rahul Jan · Gradians Wealth

partial

How will you achieve 12-15% EBITDA growth given flattish Q1?

the AIA guidance that we had given was on the standalone basis. this time anyway we have a standalone basis AITA increase of almost 14% YI...

Ajas Lakhani · Unifi AMC

direct

Excluding plant shutdown, any impact of pricing/volume/seasonality?

No, there have been no impact on uh any of these things. Basically, uh as we have disclosed the product uh sales mix...

Ajas Lakhani · Unifi AMC

partial

When will Ganesh Polym break even and contribute to bottom line?

No, in Ganesh Polym last year we we had a good AITA uh of around uh uh 60 crores and and uh this year uh you know we took a shutdown... post that I think we have restarted our plant in July and I think the current quarter we will uh reach to normaly of volume and demand

Ankit Gupta · Bamboo Capital

evasive

Can API segment still grow 10-15% in FY26 after Q1?

Yeah. Yeah. See uh what has happened is that last uh year last quarter we push lot of sales... I think there's some seasonality also to it. ... as I have mentioned we will be able to grow this business.

Ankit Gupta · Bamboo Capital

direct

What is the growth outlook for Zanthin segment over 2-3 years?

Overall I think 2 years down the line we are looking at 1,000 cr plus stop line for this segment...

Ankit Gupta · Bamboo Capital

evasive

Will CDMO continue to grow 30-40% in FY27-28?

in three four years we want all segments to grow up to 100 million or thousand cr... it depends on a year and how the approvals come...

Danil Desai · Turtle Capital

partial

Will revenue from new Atali site be incremental?

Now overall uh you know we have uh multiple sites which ultimately feed into the CDMO business as well as the intermediate business and I think you will see a increase in both top line.

Mada · Fidelity

evasive

Why is peak Zanthin revenue only 1,000 cr with 80% capacity addition?

So it all depends on how the approvals are coming through. ... So it can be anything. Yeah.

Shuba Magarval · Burman Capital

declined

What are segment-level margins and company margin outlook?

I think we are not giving the segmental uh margins but as I mentioned in past the margin profile in CDMO CMO is the highest...